Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

14. Stockholders' Equity (Details Narrative)

14. Stockholders' Equity (Details Narrative) - USD ($)	3 Months Ended	4 Months Ended		5 Months Ended		6 Months Ended	8 Months Ended			9 Months Ended	11 Months Ended	12 Months Ended
14. Stockholders' Equity (Details Narrative) - USD ($)	Jul. 12, 2018	Jul. 31, 2018	Jul. 27, 2017	Nov. 30, 2019	Aug. 22, 2017	Oct. 04, 2018	Nov. 26, 2019	Nov. 21, 2018	Dec. 01, 2017	Jan. 02, 2018	Mar. 02, 2018	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2018	Nov. 29, 2019	Jun. 19, 2019	Jun. 18, 2019
Common stock outstanding												1,777,483	1,316,335			1,328,891	11,972,328
Proceeds from sale of stock, net												$ 0	$ 4,743,000
Issuance of common stock for services, amount													59,000
Stock-based compensation												$ 839,000	1,635,000
Benchmark Securities [Member]
Issuance of common stock for services, shares		765
Stock price		$ 19.62
Stock-based compensation													15,000
Actual, Inc. [Member]
Issuance of common stock for services, shares	1,971		285		343				609	526
Stock price	$ 22.32		$ 60.66		$ 49.77				$ 45.18	$ 52.29
Issuance of common stock for services, amount					$ 35,000
Stock-based compensation													$ 44,000	$ 90,000
Public Offering [Member]
Stock issued new, shares issued				446,577
Proceeds from sale of stock, gross								$ 5,530,000
Proceeds from sale of stock, net								$ 4,743,000
Preferred stock converted								8
Common stock issued upon conversion								90,000
Stock price															$ 3.50
Public Offering [Member] \| Dawson James Securities, Inc. [Member]
Payment of stock issuance costs								$ 167,500
Public Offering [Member] \| Benchmark Securities [Member]
Payment of stock issuance costs								$ 74,000
Public Offering [Member] \| Common Stock [Member]
Stock issued new, shares issued								507,156
Public Offering [Member] \| Series C Preferred Stock [Member]
Stock issued new, shares issued								10
Public Offering [Member] \| Warrants [Member]
Stock issued new, shares issued								307,188
Public Offering [Member] \| Warrants [Member] \| Dawson James Securities, Inc. [Member]
Stock issued new, shares issued								7,639
Warrants maturity date								Nov. 16, 2023
Warrants exercise price								$ 9.00
Registered Direct Offering [Member] \| Units [Member] \| Dawson James Securities, Inc. [Member]
Stock issued new, shares issued											46,000
At Market Issuance Sales Agr [Member]
Stock issued new, shares issued						12,556							29,710
Proceeds from sale of stock, gross													$ 999,000
Proceeds from sale of stock, net													$ 957,000
Stock price						$ 21.51
At Market Issuance Sales Agr [Member] \| Common Stock [Member]
Stock issued new, shares issued						12,556
Proceeds from sale of stock, net						$ 262,000
Stock price						$ 21.51
Private Placement [Member]
Stock issued new, shares issued							446,577
Proceeds from sale of stock, gross							$ 1,563,000
Proceeds from sale of stock, net							$ 1,376,000
Stock price							$ 3.50